An insurance company shares a frightening data on increase in breast cancer

New Delhi: It is really an intimidating figure of breast cancer for Indian women. Religare Health Insurance has claimed breast cancer has jumped from 23% in 2014 to 38% in 2018 out of total cancer claims the insurance provider has received. It is really a huge jump and a waking call for women.

This report from insurance company comes hot on the heels of a report by CII that highlights that breast cancer is the most common type of cancer which afflicts women in India. As per the report, by 2026 we will witness rise in the breast cancer incidence to 35 per 100,000 women as compared to the present rate of 25.8.

The Lancet data reveals that the age standardized incidence rate of breast cancer in females has increased by 39.1% from 1990 to 2016 across the country, and the trend was observed in every state.

According to CII report cancer burden in India has more than doubled over the last 26 years, the highest increase amongst all therapy areas, with breast cancer being the most common among Indian women. The Breast Cancer Landscape in India, a white paper by the Confederation of Indian Industry (CII), which aims to provide insights regarding status and challenges in breast cancer care was released Thursday by Minister of State for Health Anupriya Patel.

As per the ICMR data, India had 14 lakh cancer patients in 2016 and this number is expected to increase. The government has laid down four priority cancers — breast cancer, cervical cancer, oral cancer and lung cancer which together constitute 41 per cent of cancer burden, the report mentioned.

Breast cancer is currently the most common cancer among Indian women, both in terms of incidence as well as mortality, with proportional prevalence in younger age-groups being higher than the global average.

Related Posts

IPC releases draft NFI-2026 to promote rational use of medicines

Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

An Impacted Denture accidently  had lodged inside it New Delhi: In a remarkable medical achievement, doctors at Sir Ganga Ram Hospital successfully removed an impacted dental plate that had accidentally…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Boehringer Ingelheim launches AI centre for pharma research in London

Boehringer Ingelheim launches AI centre for pharma research in London

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March